The pharmaceutical market worldwide, after having experienced exponential growth over the past few years, is now witnessing a slump. This decline in global pharma market is largely attributed to the patent expiry of key blockbusters together with saturation in key pharma markets such as the US and Western Europe. Meanwhile, pharma markets in some developing regions like Asia and Latin America have been continuously witnessing robust growth rate in last few years on account of increasing prevalence of diseases, rising healthcare spending and increasing affordability. Overall, these markets enjoy good growth potential in coming few years.
According to our latest research “Global Pharmaceutical Market Forecast to 2012”, global pharma industry is projected to grow at a CAGR of around 6% during 2010-2012. The growth will be driven by low cost factor, increasing prevalence of diseases worldwide and rising per capita income of consumers. Our research identifies that sales of generic drugs will emerge as the most prominent segment of the pharma market over the forecast period, indicating large opportunities for generics manufacturers to tap.
Our regional level analysis finds that the pharma industry is growing at a rapid rate in the emerging countries like India, China, Brazil, Russia, among others, while a slowdown in the growth has been encountered in the US and Western European countries. Besides this, we have found that growing inorganically via means of Mergers & Acquisitions has emerged as the most viable way for the companies to expand/extend their reach at a faster rate and maintain their revenues. We anticipate this trend to continue in near future also.
“Global Pharmaceutical Market Forecast to 2012” provides a comprehensive analysis of every major pharmaceutical market worldwide. North America, Latin America, Europe, Asia-Pacific and Africa have been selected as the most important regions to be presented in this report. The report contains statistical and analytical information on each of these markets, covering their current market size, demand and healthcare statistics. It also features analysis of future directions, supplemented with facts and figures.
